Aedifica NV/SA (EBR:AED)

Intra-Cellular Therapies Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,086	2,672	3,027	3,021	4,172	3,244
Market Cap Growth	16.57%	-11.70%	0.18%	-27.58%	28.62%	23.18%
Enterprise Value	5,714	5,263	5,381	5,464	6,219	5,000
Last Close Price	64.90	53.88	59.50	65.89	96.79	81.40
PE Ratio	17.55	13.05	123.36	9.11	14.80	28.11
PS Ratio	8.54	7.71	9.43	10.82	17.19	18.16
PB Ratio	0.87	0.73	0.85	0.92	1.50	1.49
P/OCF Ratio	10.57	10.75	13.19	13.82	21.04	26.87
EV/Sales Ratio	15.81	15.19	16.76	19.57	25.62	28.00
EV/EBITDA Ratio	18.64	17.99	19.99	23.22	31.02	34.51
EV/EBIT Ratio	18.83	18.17	20.26	23.57	31.14	34.69
Debt / Equity Ratio	0.76	0.71	0.66	0.77	0.78	0.82
Debt / EBITDA Ratio	8.76	8.90	8.80	10.76	10.76	12.18
Asset Turnover	0.06	0.06	0.05	0.05	0.05	-
Quick Ratio	0.16	0.11	0.15	0.09	0.11	0.06
Current Ratio	0.35	0.32	0.31	0.26	0.21	0.08
Return on Equity (ROE)	4.95%	5.67%	0.66%	10.92%	11.41%	-
Return on Assets (ROA)	2.96%	2.86%	2.71%	2.58%	2.71%	-
Return on Capital (ROIC)	3.06%	2.97%	2.82%	2.69%	2.80%	-
Earnings Yield	5.70%	7.66%	0.81%	10.98%	6.75%	3.56%
Dividend Yield	6.01%	7.24%	6.39%	5.62%	3.51%	3.77%
Payout Ratio	105.58%	81.46%	472.75%	35.89%	16.94%	75.21%
Buyback Yield / Dilution	-0.06%	-8.79%	-14.67%	-9.55%	-31.06%	-6.04%
Total Shareholder Return	5.97%	-1.56%	-8.29%	-3.94%	-27.55%	-2.28%

Updated Feb 19, 2025. Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.